IL6 and rheumatoid arthritis: The proinflammatory cytokine interleukin-6 (IL-6) is a key player in innate immunity and joint inflammation including human rheumatoid arthritis (RA) [1–4], and therefore it has been developed into a target of disease-modifying drugs.